|
Jan 16
|
Jim Cramer on Arbutus Biopharma Corporation (ABUS): ‘It Loses Money’
|
|
Jan 15
|
Kymera Therapeutics (KYMR) Moves 7.8% Higher: Will This Strength Last?
|
|
Oct 1
|
Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
|
|
Aug 1
|
Arbutus Biopharma (ABUS) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 1
|
Arbutus: Q2 Earnings Snapshot
|
|
Aug 1
|
Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
|
Jun 13
|
Ultragenyx (RARE) Moves 7.8% Higher: Will This Strength Last?
|
|
Jun 5
|
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg, a Necessity for HBV Functional Cure
|
|
May 3
|
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
|
May 3
|
Arbutus Biopharma Corp (ABUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 2
|
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
|
|
May 2
|
Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 2
|
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
|
May 2
|
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
|
|
Apr 30
|
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
|
|
Apr 18
|
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
|
|
Apr 4
|
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
|
|
Apr 1
|
Is Arbutus Biopharma (NASDAQ:ABUS) In A Good Position To Deliver On Growth Plans?
|
|
Mar 8
|
Arbutus to Participate in Two Upcoming Investor Conferences
|